CollPlant Biotechnologies (CLGN) Accounts Payables (2018 - 2025)

CollPlant Biotechnologies' Accounts Payables history spans 8 years, with the latest figure at $610000.0 for Q4 2025.

  • For Q4 2025, Accounts Payables fell 29.89% year-over-year to $610000.0; the TTM value through Dec 2025 reached $610000.0, down 29.89%, while the annual FY2025 figure was $610000.0, 29.89% down from the prior year.
  • Accounts Payables reached $610000.0 in Q4 2025 per CLGN's latest filing, down from $870000.0 in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $1.1 million in Q4 2022 to a low of $610000.0 in Q4 2025.
  • Average Accounts Payables over 5 years is $925400.0, with a median of $980000.0 recorded in 2023.
  • Peak YoY movement for Accounts Payables: increased 29.57% in 2021, then decreased 29.89% in 2025.
  • A 5-year view of Accounts Payables shows it stood at $1.0 million in 2021, then grew by 9.57% to $1.1 million in 2022, then dropped by 13.5% to $980000.0 in 2023, then fell by 11.22% to $870000.0 in 2024, then fell by 29.89% to $610000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLGN's Accounts Payables are $610000.0 (Q4 2025), $870000.0 (Q4 2024), and $980000.0 (Q4 2023).